The varied application of surgery to the initial treatment of 908 cases of primary ovarian cancer is analysed. In patients with advanced disease (FIGO Stages lIb, III and IV) 256 (46%) of 555 women achieved minimal residual disease status by primary surgery and this proportion fell to 24% when only stages III and IV were considered; of these cases 7% underwent adjunctive intestinal resection or urinary tract surgery. Although not in a clinical trial situation the women achieving minimal residual disease status before chemotherapy survived better in the short term, although long-term survival remained disappointing.
Introduction
Whatever improvements may occur in the ability of clinicians to diagnose malignant disease of the ovaries, both definitive diagnosis and primary treatment are likely to remain surgical. Although not readily testable in a randomized study there is a body of circumstantial evidence which suggests that the macroscopic completeness of primary surgical treatment is one of the most important factors for survival in this condition, whatever adjunctive treatment is used-". In the United States and Australia, countries where the sub-specialty of gynaecological oncology is well developed, it is widely accepted that complete macroscopic removal of all pelvic tumour is usually possible" and that where there is tumour extension beyond the ovary dissection should be carried out in a retroperitoneal plane removing the attached part of the pelvic peritoneum as a 'false capsule' to the tumour", Where necessary this will include a limited restorative resection of the rectosigmoidv'. It is now commonly accepted that an extensive pelvic operation of this order is also justifiable even if a small amount of macroscopic disease be left in the upper abdominal cavity, provided that no individual tumour mass should exceed 2 em in diameter -in practice an upper limit of 0.5-1 em would be preferred''", Occasionally quite major upper abdominal resections have been carried out but these will, in practice, be most unusual. Parenchymal disease of the liver advances the FIGO stage to four. Serosal deposits on the surface of the liver are generally quite small and often inaccessible in the region of the subphrenic attachment of the liver. They do not themselves contra-indicate radical cytoreductive surgery.
The hazards of operating on major deposits in the porta hepatis, however, would generally contraindicate cyto-reductive surgery in this area, but even this situation may change if the use of the argon laser or high frequency ultrasound for tumour nodule reduction proves to be safe against a tumour bed such as the Iiver".
In the United Kingdom, because initial surgical therapy of ovarian cancer tends to be carried out by generalist gynaecologists and general surgeons, it is pertinent to examine the extent to which the objective of optimal cyto-reduction is attempted or achieved in the district and teaching hospitals of a single health region in the United Kingdom. This report, therefore, covers the surgical treatment of over 900 cases of primary ovarian malignancy in the North East Thames Region, prospectively documented and followed up for a minimum of 5 years or until death.
Methods and patients
In the 1970s a prospective data bank on ovarian cancer was set up by the Association of Obstetricians and Gynaecologists of the North East Metropolitan Region in association with the regional histopathologists of the Region with central review of the pathology including the establishment of a local tumour reference panel for doubtful, unusual and interesting cases lO • ll • Entry was made by pathologists or clinicians, and as soon as a case was notified clinical data on a common proforma were obtained from the surgeon concerned providing details of the presentation, staging, primary procedure and primary adjunctive therapy. Duplicate histological material was made available for central review. Follow-up data were requested on an annual basis with a record of progress, treatment on relapse (if any), and eventual outcome.
Data handling
One thousand and thirty-one cases were entered. Four cases had insufficient presentation data and were not followed up. Entry was accepted with cytology alone only ifFlGO criteria for special stage allocation were met; 25 patients were therefore not subject to surgical diagnosis. Of the remainder, 65 were considered to have ovarian malignancy secondary to an identified primary tumour elsewhere and were excluded from consideration as were an additional 29 cases for which there was insufficient information or inadequate material for classification (eg, carcinomatosis peritonei of uncertain origin or cytology only).
This report covers the surgical treatment of 908 cases of primary ovarian cancer. Follow-up to death or a minimum of 5 years was achieved in 96%.
The data were collected on cards and subsequently stored on computer programme SPSS-X-version 1, using an ICL Mainframe Computer. In no sense was this a controlled clinical trial, but it has been possible to subject the various therapeutic subgroups to analysis of commonly accepted prognostic variables such as grade, histological type and differentiation.
Staging
A stage was allocated to each patient on the basis of information in accordance with the extant FlGO staging scheme. A corresponding TNM stage was also allocated according to the DICC classification.
Definition of surgery
Ovarian surgery The extent of surgery on the ovaries was recorded as (a) biopsy only, (b) partial resection (cyst enucleation), (c) unilateral complete removal (other ovary conserved) and (d) bilateral or total oophorectomy (no ovary conserved); applicable also if a contralateral ovary had been previously removed.
Uterine surgery Uterine surgery was recorded as (a) uterus retained, (b) uterus previously removed or (c) hysterectomy.
Radical oophorectomy Features of surgery more extensive than the traditional total hysterectomy, bilateral salpingo-oophorectomyand omental resection were recorded as (a) removal of pelvic peritoneum, (b) urinary tract operation, (c) intestinal resection, (d) colostomy, (e) lymphadenectomy and (f) other. It is the extraperitoneal mobilization of the pouch of Douglas including the rectum, enabling removal of attached pelvic peritoneum, with or without colonic resection, that constitutes radical oophorectomyt-.
Tumour residuum
The all-important residual tumour burden was described as: (a) Palliative surgery leaving bulky residual disease.
(i) Biopsy only. (ii) Removal of main tumour mass with widespread residual disease (sub-optimal 'debulking'). (ii) Visibly complete operation with clean removal (optimal surgery for strictly localizeddisease).
Treatment groups
From the complex features of staging and variable surgical procedures three groups emerge for which a differing natural history might be anticipated.
Strictly localized disease In these cases disease which was histologically and clinically confined to the ovary was completely removed. The only pertinent surgical detail in this group is the possible application of Journal of the Royal Society of Medicine Volume 84 April 1991 207 conservation of reproductive function in the younger patient. Historically it is recognized that this group has commonly been understaged with particular reference to occult subphrenic disease-". There were 146 cases of epithelial cancer in this group.
Intermediate disease This consisted of cases with strong presumptive evidence of extra-ovarian extension or spread, but in whom optimal surgical cytoreduction has nevertheless been achieved. There were 393 cases of epithelial cancer in this group which is sub-divided into two important divisions, namely those with macroscopic clearance and those with minimal visible residual disease. The sub-group with macroscopic clearance includes stage I disease with capsular disruption or ascites, most patients in stage II and some in stage III (rarely stage IV) in whom macroscopic surgical cyto-reduction has been achieved. Traditional surgery consisting of bilateral salpingooophorectomy, hysterectomy and removal of omentum can normally only achieve macroscopicpelvic clearance in stages I and IIa because in such cases visible extension is confined to the uterus, tubes and broad ligaments. A few patients with localized pelvic disease but with isolated metastases confined to the omentum can be macroscopically cleared by the traditional surgery, but are included in stage III. In stage lIb and the remainder of stage III, however, because there is extension or metastasis outside the genital tract, it is axiomatic that some form of radical oophorectomy is necessary to achieve macroscopicclearance. Some cases with more extensive pelvic extension will also require limited rectosigmoid resection and/or occasionally small bowel or partial bladder resection':'.
Advanced disease Those individuals for whom no operation other than biopsy was possible, or in whom removal only ofthe main tumour masses, (ovaries and omentum) with bulky residual disease had taken place. These numbered 269 cases of epithelial cancer.
Obviously the distribution of cases between intermediate and advanced disease will be influenced not only by the distribution and extent of the disease but by the willingness of the initial surgeon to extend the field of surgical endeavour as well.
Results

Localized disease
With bilateral but localized disease (stages Ib and Ic) bilateral (total) oophorectomy was the norm and uterine conservation was not recommended. Hysterectomy was, however, omitted in 25% of these cases (15/60). With unilateral localized disease conservative surgery on the uterus and other ovary was commonly only considered in the younger age group, but because of the therapeutic success of modern management of germ cell tumours this approach should now be considered preferred initial management in the under 30 years age group", Total removal of the ovaries (castration) was carried out in 3% of women under the age of 30 with unilateral disease. Conversely, total (or bilateral) oophorectomy was not carried out in 16% of women over the age of 40 with ovarian malignancy, mostly in operations by other than gynaecological surgeons.
In the under 40 years age group microscopic involvement of an apparently normal second ovary was found in only one case. If an apparently normal Survival in months complete macroscopic clearance was achieved, and 12 out of 166 cases (7%), in which minimal residual disease status was achieved.
Discussion
It is clear that there is very considerable variation in the way in which surgery is used in the primary treatment of this disease. Studies from the United States indicate that optimal cyto-reductive surgery in advanced disease can be achieved in some 85% of cases operated upon by specialist gynaecological oncologists, in contrast to the rates (circa 30%) achieved by either generalist gynaecologists or general surgeons'? Perhaps the most important observation by any standards in this series from the United Kingdom is that optimal cyto-reduction was relatively infrequently achieved, (29% in stages III and IV) and that the overall median and 5-year survival is substantially worse than most reports of other current series would indicate. In nearly all such series residual tumour burden remains one of the most important indications of prognosis and these data, although uncontrolled, are supportive. Failure to achieve minimal residual disease status in spite of alleged 'debulking' must be the most obvious factor in this series.
The outstanding question is how may optimal surgery for ovarian cancer be achieved in the era of increasing subspecialization. Perhaps the most important message is to dispel the prevalent myth that 'debulking' short of adequate clearance is acceptable in the majority of cases". An inadequate 'debulking' operation is probably less to the benefit of the patient than biopsy and closure which allows a planned maximal surgical effort at a later date.
Although tertiary referral of cervical and vulval cancer has been readily accepted, it will be more difficult to achieve this for ovarian cancer. Modern imaging and the use of tumour markers may improve the precision of diagnosis enabling the correct disposition of resources for the primary procedure; nevertheless the concept of elective re-operation should be acknowledged as good clinical practice where optimal surgery is unlikely to be achieved at initial laparotomy. This is particularly the case if pelvic clearance cannot be achieved without rectosigmoid resection and anastomosis.
Such a procedure is outside the scope of practice of many generalist obstetricians and gynaecologists. It should, however, be within the competence of any generalist with a special interest in gynaecological oncology and may be appropriate in up to 25% of cases of advanced disease? The temptation is to rationalize away the limited need for this type of surgery.
In many district hospitals it will not be possible for exclusive oncological subspecialization to be economically feasible in the foreseeable future. Nor are we near to achieving tertiary referral for untreated ovarian cancer. Collaboration between colleagues with differing subspecialty interests is thus to be encouraged. Patients with potentially malignant ovarian masses should not be left to unsupported trainee surgeons, and those who profess a special interest in gynaecological oncology should be comfortable with the limited and relatively straightforward intestinal surgery, which is sometimes now part of the optimal management-". 
Extra-genital surgery
Operative incursions into adjacent viscera were recorded in 13 out of 109 cases (12%) in which ovary is to be retained in a younger woman with localized unilateral disease this is the argument for inclusion of ovarian slice biopsy in the staging procedure. 
Utilization of extended surgery
The use of a radical oophorectomy technique to achieve optimal cyto-reduction has remained relatively uncommon in the United Kingdom until recently. The non-specific term 'debulking' has been applied to a variety of procedures most of which fall short of optimal cyto-reductive surgery. In this series the full traditional procedure of total hysterectomy together with removal ofthe omentum in addition to bilateral oophorectomy was only recorded in 12% of cases in FIGO Stage III. In the remainder some lesser procedure was carried out, even though apparent minimal residual disease status was recorded in some cases.
Extended surgery was utilized to achieve complete macroscopic clearance in 50% of 183 cases in stage lIb (and in 17 cases of stage III and IV disease in which stage III was allocated by virtue of direct involvement of small bowel, omentum or anterior abdominal wall without obvious metastasis). Otherwise in stages III and IV disease optimal cyto-reduction with minimal residual disease was achieved in 85 out of 372 cases (24%). The features of the radical oophorectomy technique were only mentioned in 20 cases so that in the majority visible pelvic clearance will not have been achieved. Figure 1 illustrates the survival in stages lIb, III and IV of three subgroups, namely patients with macroscopic clearance, optimal but incomplete cyto-reduction, and those with suboptimal clearance treated with chemotherapy. There are no significant differences in grade or differentiation but clearly the completeness of surgery must be related to the extent of disease. In the years concerned, single agent alkylating agent therapy was the commonest form of chemotherapy. Cisplatin became available in the later years and was most commonly used for relapse. The MRC multicentre study comparing single alkylating therapy with a three drug combination occurred during the period of the study!".
